Tech Company Financing Transactions
Micronoma Funding Round
Seerave Foundation and Symbiosis invested in a $3.5 million funding round for Micronoma. This venture round was recorded on 2/23/2021.
Transaction Overview
Company Name
Announced On
2/23/2021
Transaction Type
Debt
Amount
$3,500,000
Round
Undisclosed
Investors
Proceeds Purpose
The company intends to use the funds to complete its validation study on lung cancer prediction, set up CLIA (Clinical Laboratory Improvement Amendments) operations, establish its go-to-market strategy utilizing its Oncobiota platform, and initiate work on a second cancer target.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
4616 Whispering Woods Ct.
San Diego, CA 92130
USA
San Diego, CA 92130
USA
Phone
Undisclosed
Website
Email Address
Overview
Micronoma is the first cancer-detection company using liquid biopsy technology to detect and predict cancer by interrogating the microbial signal with clinical-grade accuracy at an early stage of the disease. Micronoma was founded by leaders in microbiome research, and committed to improving the lives of all involved in cancer diagnosis.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Sandrine Miller
Co-Founder
Magda Marquet
Founder
Robert Knight
Founder
Gregory Poore
Browse more venture capital transactions:
Prev: 2/23/2021: nanit venture capital transaction
Next: 2/23/2021: Promise venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC transactions reported here are sourced from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs